| Lifetime cancer risks in individuals with germline PTEN mutations MH Tan, JL Mester, J Ngeow, LA Rybicki, MS Orloff, C Eng Clinical Cancer Research 18 (2), 400-407, 2012 | 1077 | 2012 |
| The global state of the genetic counseling profession MA Abacan, L Alsubaie, K Barlow-Stewart, B Caanen, C Cordier, ... European Journal of Human Genetics 27 (2), 183-197, 2019 | 375 | 2019 |
| Failure-free survival and radiotherapy in patients with newly diagnosed nonmetastatic prostate cancer: data from patients in the control arm of the STAMPEDE trial ND James, MR Spears, NW Clarke, DP Dearnaley, MD Mason, CC Parker, ... JAMA oncology 2 (3), 348-357, 2016 | 348* | 2016 |
| Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations TR Rebbeck, TM Friebel, E Friedman, U Hamann, D Huo, A Kwong, ... Human mutation 39 (5), 593-620, 2018 | 343 | 2018 |
| Global epidemiology and genetics of hepatocellular carcinoma MR Toh, EYT Wong, SH Wong, AWT Ng, LH Loo, PKH Chow, J Ngeow Gastroenterology 164 (5), 766-782, 2023 | 290 | 2023 |
| Incidence and clinical characteristics of thyroid cancer in prospective series of individuals with Cowden and Cowden-like syndrome characterized by germline PTEN, SDH, or KLLN … J Ngeow, J Mester, LA Rybicki, Y Ni, M Milas, C Eng The Journal of Clinical Endocrinology & Metabolism 96 (12), E2063-E2071, 2011 | 223 | 2011 |
| The DNA structure-specific endonuclease MUS81 mediates DNA sensor STING-dependent host rejection of prostate cancer cells SSW Ho, WYL Zhang, NYJ Tan, M Khatoo, MA Suter, S Tripathi, ... Immunity 44 (5), 1177-1189, 2016 | 212 | 2016 |
| High SUV uptake on FDG–PET/CT predicts for an aggressive B-cell lymphoma in a prospective study of primary FDG–PET/CT staging in lymphoma JYY Ngeow, RHH Quek, DCE Ng, SW Hee, M Tao, LC Lim, YH Tan, ... Annals of oncology 20 (9), 1543-1547, 2009 | 191 | 2009 |
| Clinical characterization of the pheochromocytoma and paraganglioma susceptibility genes SDHA, TMEM127, MAX, and SDHAF2 for gene-informed prevention B Bausch, F Schiavi, Y Ni, J Welander, A Patocs, J Ngeow, U Wellner, ... JAMA oncology 3 (9), 1204-1212, 2017 | 185 | 2017 |
| PTEN-opathies: from biological insights to evidence-based precision medicine L Yehia, J Ngeow, C Eng The Journal of clinical investigation 129 (2), 452-464, 2019 | 166 | 2019 |
| Gene‐specific criteria for PTEN variant curation: Recommendations from the ClinGen PTEN Expert Panel JL Mester, R Ghosh, T Pesaran, R Huether, R Karam, KS Hruska, ... Human mutation 39 (11), 1581-1592, 2018 | 165 | 2018 |
| Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation SR Plotkin, L Messiaen, E Legius, P Pancza, RA Avery, JO Blakeley, ... Genetics in Medicine 24 (9), 1967-1977, 2022 | 145 | 2022 |
| Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta‐analysis JN McAlpine, DS Chiu, RA Nout, DN Church, P Schmidt, S Lam, S Leung, ... Cancer 127 (14), 2409-2422, 2021 | 142 | 2021 |
| Understanding the psychological impact of COVID-19 pandemic on patients with cancer, their caregivers, and health care workers in Singapore KYY Ng, S Zhou, SH Tan, NDB Ishak, ZZS Goh, ZY Chua, JMX Chia, ... JCO global oncology 6, 1494-1509, 2020 | 137 | 2020 |
| Second Malignant Neoplasms in Patients With Cowden Syndrome With Underlying Germline PTEN Mutations J Ngeow, K Stanuch, JL Mester, JS Barnholtz-Sloan, C Eng Journal of Clinical Oncology 32 (17), 1818-1824, 2014 | 130 | 2014 |
| Familial non-medullary thyroid cancer: unraveling the genetic maze SP Yang, J Ngeow Endocrine-related cancer 23 (12), R577-R595, 2016 | 129 | 2016 |
| Breast cancer risk and clinical implications for germline PTEN mutation carriers J Ngeow, K Sesock, C Eng Breast cancer research and treatment 165, 1-8, 2017 | 126 | 2017 |
| European polygenic risk score for prediction of breast cancer shows similar performance in Asian women WK Ho, MM Tan, N Mavaddat, MC Tai, S Mariapun, J Li, PJ Ho, J Dennis, ... Nature communications 11 (1), 3833, 2020 | 124 | 2020 |
| Prognostic factors in patients with diffuse large B cell lymphoma: before and after the introduction of rituximab L Ngo, SW Hee, LC Lim, M Tao, R Quek, SP Yap, EL Loong, I Sng, ... Leukemia & lymphoma 49 (3), 462-469, 2008 | 124 | 2008 |
| Tissue microbiome profiling identifies an enrichment of specific enteric bacteria in Opisthorchis viverrini associated cholangiocarcinoma KR Chng, SH Chan, AHQ Ng, C Li, A Jusakul, D Bertrand, A Wilm, ... EBioMedicine 8, 195-202, 2016 | 118 | 2016 |
